COLLEEN ROSE: Open Payments
NPI 1871753566 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 26 payments from 9 companies in 2025. Trend: 2023 $615 · 2024 $541 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $216 |
| AstraZeneca Pharmaceuticals LP | 3 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Baxter Healthcare | 2 | $44 |
| ABBVIE INC. | 1 | $33 |
| Viatris Specialty LLC | 1 | $23 |
| Electromed, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: DUPIXENT, FASENRA, Hillrom - Volara System, OFEV, LINZESS, YUPELRI, JASCAYD, SMARTVEST.
Industry payments across CA — which companies pay providers there.
